Semaglutide is a GLP-1 receptor agonist medication approved for the treatment of type 2 diabetes (marketed as Ozempic and Rybelsus) and chronic weight management (marketed as Wegovy). It works by mimicking the GLP-1 hormone to regulate blood sugar, reduce appetite, and slow gastric emptying, leading to significant improvements in glycemic control and weight loss.
⚠️ Research Use Only: This product is intended strictly for laboratory and in-vitro research purposes only. Not approved for human or veterinary use. Not intended for ingestion, injection, or any form of human or animal consumption. By purchasing, you confirm you are a qualified researcher and will handle this product in accordance with applicable laws and regulations.
Reviews
There are no reviews yet.